BCAX
BCAX
US0554771032
Bicara Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.16B EUR
1.95B EUR
1.3B EUR
952.59M EUR
Enterprise Value
646.05M EUR
1.85B EUR
981.71M EUR
857.62M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.97x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.46x
4.15x
2.54x
2.37x
EV/Revenue
--
--
--
--
EV/EBITDA
-3.2x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.64%
-6.95%
-8.94%
-8.29%
ende